Biotech news
Americas
Hector Chagoya and Mariana Gonzalez-Vargas of Becerril, Coca & Becerril examine how Mexico applies the Budapest Treaty, which covers microorganisms in the patent process. 29 November 2018
Biotech
Despite the importance of IP rights to biotech and biopharma innovation, recent decisions and new policies are weakening and reducing the scope of IP-based incentives, according to a report. 27 November 2018
Asia-Pacific
Scientists have urged policymakers to implement a regulatory framework governing the use of CRISPR technology in humans, following reports that a Chinese scientist has successfully created ‘edited’ twins. 26 November 2018
Biotech
The global CRISPR technology market is expected to reach $1.72 million in value by 2023, up from 2018’s predicted figure of $562 million, according to a report released this month. 23 November 2018
Americas
Saul Ewing Arnstein & Lehr has strengthened its Boston office with the addition of two life sciences partners from Hamilton, Brook, Smith & Reynolds. 23 November 2018
Americas
Genome sequencing company 10x Genomics has been accused of infringing 11 patents covering cell research and analysis tools. 20 November 2018
Pharma
While the pharmaceutical industry has welcomed the draft Withdrawal Agreement for the UK’s departure from the EU, more clarity is still needed, lawyers have told LSIPR. 16 November 2018
Americas
The speed of technological advancements in the life sciences industry is forcing patent lawyers to consider whether the norms they’re used to dealing with in the profession still apply. 15 November 2018
Americas
Technology company IBM is seeking to patent the use of blockchain in open scientific research, including experiments, data collection, and analysis. 14 November 2018
Americas
Gene-editing company CRISPR Therapeutics has expanded its partnership with US-based MaxCyte, which focuses on cell-based medicines, into the immuno-oncology arena. 13 November 2018